Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2005
06/16/2005US20050131026 Bronchitis; chronic obstructive pulmonary disease; antihistamines; pneumonia
06/16/2005US20050131009 Urea substituted imidazoquinolines
06/16/2005US20050131000 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
06/16/2005US20050130998 Central nervous ystem diorders; Alzheimer's disease ; anticancer agents
06/16/2005US20050130990 especially dimethylphenylpiperazinium; treating a variety of pulmonary diseases with fewer side effects than other anti-inflammatory drugs, such as steroids
06/16/2005US20050130965 Inhibitors of p38 kinase
06/16/2005US20050130964 e.g 8-oxa-1-thia-benzo[e]naphtho[3,2-h]azulene-2-carboxylic acid ethyl ester; rheumatoid arthritis
06/16/2005US20050130948 Therapeutic methods and uses of sapogenins and their derivatives
06/16/2005US20050130947 6alpha, 9alpha-Difluoro-17alpha-((2-furanylcarbonyl)oxy)-11beta-hydroxy-16alpha-methyl-3-oxo-androsta-1,4-diene-17beta-carbothioic acid S-fluoromethyl ester completely dissolved in a liquified hydrofluoroalkane (HFA) gas as propellant; for asthma or chronic obstructive pulmonary disease (COPD)
06/16/2005US20050130935 Combination of a beta-2-adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
06/16/2005US20050130881 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
06/16/2005US20050130304 Regulation of endogenous gene expression in cells using zinc finger proteins
06/16/2005US20050130286 For diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders
06/16/2005US20050130209 Expression vector comprising nucleotide sequences coding deoxyribonuclease for use as tool in treatment and prevention of cystic fibrosis
06/16/2005US20050130145 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, and agonists; drug screening
06/16/2005US20050130127 Coronavirus-like particles comprising functionally deleted genomes
06/16/2005US20050129784 Use of a chemically stabilized chlorite solution for inhibiting an antigen-specific immune response
06/16/2005US20050129739 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
06/16/2005US20050129736 Compositions and methods for treating or preventing diseases of body passageways
06/16/2005US20050129625 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant
06/16/2005US20050129623 Inhalable aztreonam aerosol for treatment and prevention of pulmonary bacterial infections
06/16/2005US20050129622 Nasal composition comprising a mucopolysaccharide and propylene glycol
06/16/2005CA2548072A1 Inhalable tiotropium and container therefor
06/16/2005CA2547782A1 Medical product containing tiotropium
06/16/2005CA2547781A1 A medical product comprising tiotropium in a moisture-proof container
06/16/2005CA2547660A1 Method for administration of tiotropium
06/16/2005CA2547245A1 Pre-metered dry powder inhaler for moisture-sensitive medicaments
06/16/2005CA2546926A1 Compositions for the treatment of afflictions of the oral cavity and upper respiratory tract
06/15/2005EP1541580A1 Sulfotransferase inhibitors
06/15/2005EP1541579A1 Produrg, medicinal utilization thereof and process for producing the same
06/15/2005EP1541576A1 Furoisoquinoline derivative and use thereof
06/15/2005EP1541574A1 Triazaspiro 5.5 undecane derivatives and drugs comprisi ng the same as the active ingredient
06/15/2005EP1541573A1 Novel crystals of triazaspiro 5.5 undecane derivative
06/15/2005EP1541571A1 Bicyclic unsaturated tertiary amine compound
06/15/2005EP1541563A1 Ccr4 antagonist and medicinal use thereof
06/15/2005EP1541559A1 5-substituted isoquinoline derivative
06/15/2005EP1541149A1 Phosphodiesterase inhibitor
06/15/2005EP1541130A1 Chinese herb medicine composition in the form of jelly
06/15/2005EP1539942A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
06/15/2005EP1539933A2 Methods of organ regeneration
06/15/2005EP1539769A1 Bicyclic heteroaromatic compounds as kinase inhibitors
06/15/2005EP1539766A1 Calcitonin gene related peptide receptor antagonists
06/15/2005EP1539763A1 Azaindole kinase inhibitors
06/15/2005EP1539759A1 Use of and some novel imidazopyridines
06/15/2005EP1539758A1 Substituted pyrrolopyridines
06/15/2005EP1539757A1 Substituted pyrrolopyridines
06/15/2005EP1539753A2 Pyrazolo(3,4-b)pyridine compounds, and their use as phosphodiesterase inhibitors
06/15/2005EP1539748A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
06/15/2005EP1539742A1 Indole derivatives useful as histamine h3 antagonists
06/15/2005EP1539741A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics
06/15/2005EP1539739A1 Piperidinyl compounds that selectively bind integrins
06/15/2005EP1539732A1 Novel compounds
06/15/2005EP1539723A1 Novel use of benzothiazole derivatives
06/15/2005EP1539701A1 Caspase inhibitors and uses thereof
06/15/2005EP1539696A2 Process for preparing quinolin antibiotic intermediates
06/15/2005EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators
06/15/2005EP1539693A1 Cannabinoid receptor agonists
06/15/2005EP1539683A2 Phenol derivatives and their use as rotamase inhibitors
06/15/2005EP1539679A2 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
06/15/2005EP1539678A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands
06/15/2005EP1539674A1 Amino-propanol derivatives
06/15/2005EP1539662A1 Cannabinoid receptor ligands
06/15/2005EP1539284A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
06/15/2005EP1539179A2 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
06/15/2005EP1539164A1 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
06/15/2005EP1325007B1 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
06/15/2005EP1311259B1 Pharmaceutical composition comprising an ester of 5-aminolevulinic acid as photochemotherapeutic agent and a mucoadhesive agent
06/15/2005EP1299107B1 Highly concentrated stable meloxicam solutions
06/15/2005EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
06/15/2005EP1244625B1 4-pyridinyl-n-acyl-l-phenylalanines
06/15/2005EP1104412B1 Tace inhibitors
06/15/2005EP1064277B1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
06/15/2005EP1048658B1 Alicyclic acylated heterocyclic derivatives
06/15/2005EP0979099B1 Use of lactoferin in the treatment of allergen induced disorders
06/15/2005EP0906108B1 Endothelin antagonists for treating heart failure
06/15/2005CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion
06/15/2005CN1628113A Substituted indoles as alpha-1 agonists
06/15/2005CN1628103A Pyrimidine derivitive
06/15/2005CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
06/15/2005CN1627970A Safety shield system for prefilled syringe
06/15/2005CN1627944A Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
06/15/2005CN1626546A New method for preparing Ciclesonide medication for treating asthma disease
06/15/2005CN1626516A Novel intermediate for prepn. of pyrazolopyrimidinones
06/15/2005CN1626235A Compound preparation of forest frog, and preparation method
06/15/2005CN1626228A Extractive from decoction of rehmannia including six elements, combination of medication, and medical use
06/15/2005CN1626226A Medication for treating asthma
06/15/2005CN1626224A Injection liquid in use for intravenous injection and preparation method
06/15/2005CN1626209A Compound preparation of glycyrrhizin drop and preparation method
06/15/2005CN1626208A Preparation of fleabane and preparation method
06/15/2005CN1626199A Powder injection preparation for generating channels and vessels, and preparation method
06/15/2005CN1626197A Method for preparing external and internal remedies for treating diseases of AIDS, ulcer of oral cavity, burn and scald, and usage
06/15/2005CN1626177A Powder injection of astragalus root and preparation method
06/15/2005CN1626169A Cordate houttuynia preparation taken through nose
06/15/2005CN1626162A Method for preparing liquid of relieving asthma possible to be atomized
06/15/2005CN1626149A Medication for treating cough
06/15/2005CN1626145A Medication for treating cough
06/15/2005CN1626143A Medication for treating pharyngitis
06/15/2005CN1626141A Medication for relieving cough and asthma
06/15/2005CN1626137A Medication for treating bronchitis
06/15/2005CN1626136A Medication for treating bronchitis
1 ... 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 ... 878